Literature DB >> 33557775

HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China.

Xianwu Pang1,2, Kailing Tang1, Qin He1, Jinghua Huang1, Ningye Fang1, Xinjuan Zhou1, Qiuying Zhu1, Xiuling Wu1, Zhiyong Shen3, Shujia Liang4.   

Abstract

BACKGROUND: The widespread use of antiretroviral therapy (ART) has resulted in the development of transmitted drug resistance (TDR), which reduces ART efficacy. We explored TDR prevalence and its associated risk factors in newly diagnosed individuals in Guangxi.
METHODS: We enrolled 1324 participants who were newly diagnosed with HIV-1 and had not received ART at voluntary counselling and testing centres (VCT) in Guangxi, China, who had not received ART. Phylogenetic relationship, transmission cluster, and genotypic drug resistance analyses were performed using HIV-1 pol sequences. We analysed the association of demographic and virological factors with TDR.
RESULTS: In total, 1151 sequences were sequenced successfully, of which 83 (7.21%) showed evidence of TDR. Multivariate logistic regression analysis revealed that there was significant difference between the prevalence of TDR and unmarried status (adjusted odds ratio (aOR) = 2.41, 95% CI: 1.23-4.71), and CRF08_BC subtype (aOR = 2.03, 95% CI: 1.13-3.64). Most cases of TDR were related to resistance to non-nucleoside reverse transcriptase inhibitors (4.87%) and V179E was the most common mutation detected. We identified a total of 119 HIV transmission clusters (n = 585, 50.8%), of which 18 (15.1%) clusters showed evidence of TDR (36, 41.86%). Three clusters were identified that included drug-resistant individuals having a transmission relationship with each other. The following parameters were associated with TDR transmission risk: Unmarried status, educational level of junior high school or below, and CRF08_BC subtype may be a risk of the transmission of TDR.
CONCLUSIONS: Our findings indicated that moderate TDR prevalence and highlighted the importance of continuous TDR monitoring and designing of strategies for TDR mitigation.

Entities:  

Keywords:  Antiretroviral resistance; Antiretroviral therapy; HIV drug resistance; Human immunodeficiency virus 1; Primary antiretroviral resistance; Transmitted drug resistance

Mesh:

Substances:

Year:  2021        PMID: 33557775      PMCID: PMC7871613          DOI: 10.1186/s12879-021-05854-w

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  30 in total

1.  Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China.

Authors:  F E McClutchan; J K Carr; D Murphy; S Piyasirisilp; F Gao; B Hahn; X-F Yu; C Beyrer; D L Birx
Journal:  AIDS Res Hum Retroviruses       Date:  2002-10-10       Impact factor: 2.205

2.  [Epidemiological characteristics of HIV/AIDS in Guangxi Zhuang Autonomous Region, 2010-2017].

Authors:  X M Ge; W M Yang; Q Y Zhu; X L Wu; Z Y Shen; J H Zhu; G H Lan; H H Chen; Q Meng; X J Zhou; D N Ding; X H Liu; S Tang; J H Huang; Y Q Deng
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2019-03-10

3.  Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy.

Authors:  Guojian Li; Shujia Liang; Tim J Harrison; Zhenzhu Tang; Zhiyong Shen; Xueyan Wang; Xinghua Wu; Wei Liu; Fuxiong Liang; Liushuai Feng; Jinye Yang; Zhongliao Fang
Journal:  Intervirology       Date:  2014-06-28       Impact factor: 1.763

4.  Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

Authors:  Diane E Bennett; Ricardo J Camacho; Dan Otelea; Daniel R Kuritzkes; Hervé Fleury; Mark Kiuchi; Walid Heneine; Rami Kantor; Michael R Jordan; Jonathan M Schapiro; Anne-Mieke Vandamme; Paul Sandstrom; Charles A B Boucher; David van de Vijver; Soo-Yon Rhee; Tommy F Liu; Deenan Pillay; Robert W Shafer
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

5.  Transmitted HIV drug resistance in treatment-naive Romanian patients.

Authors:  Aura Temereanca; Luminita Ene; Sanjay Mehta; Loredana Manolescu; Dan Duiculescu; Simona Ruta
Journal:  J Med Virol       Date:  2013-04-16       Impact factor: 2.327

6.  [Distribution of HIV-1 subtypes in Guangxi Zhuang Autonomous Region, 2008-2009].

Authors:  Wei Liu; Shu-jia Liang; Jin-ye Yang; Jian-jun Li; Bin Wang; Li-li Chen; Lin Li; Yong-Jian Liu; Jing-Yun Li
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2013-01

7.  The changing HIV-1 genetic characteristics and transmitted drug resistance among recently infected population in Yunnan, China.

Authors:  M Chen; M H Jia; Y L Ma; H B Luo; H C Chen; C J Yang; J Dai; L Yang; L J Dong; R Lu; L J Song; Y Han; J Y Lu; A K L Cheung; Z W Chen; L Lu
Journal:  Epidemiol Infect       Date:  2018-03-14       Impact factor: 4.434

8.  Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.

Authors:  Yolanda Vega; Elena Delgado; Aurora Fernández-García; Maria Teresa Cuevas; Michael M Thomson; Vanessa Montero; Monica Sánchez; Ana Maria Sánchez; Lucia Pérez-Álvarez
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

9.  Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015.

Authors:  Xianfeng Wang; Xiaosong Liu; Feng Li; Hong Zhou; Jiefang Li; Yingying Wang; Lihua Liu; Shujun Liu; Yi Feng; Ning Wang
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

10.  Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing.

Authors:  Y X Song; R L Xin; Z C Li; H W Yu; W H Lun; J Ye; A Liu; A X Li; J W Li; J Z Ye; M Q Hao; H Y Lu; L J Sun
Journal:  Epidemiol Infect       Date:  2018-01-18       Impact factor: 4.434

View more
  5 in total

1.  Factors Associated With Newly HIV Infection and Transmitted Drug Resistance Among Men Who Have Sex With Men in Harbin, P.R. China.

Authors:  Shan Hui; Fangfang Chen; Yi Li; Yan Cui; Jinhui Zhang; Ling Zhang; Yisi Yang; Yanlin Liu; Yashuang Zhao; Fan Lv
Journal:  Front Public Health       Date:  2022-06-02

2.  Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China.

Authors:  Pengtao Liu; Yinghui You; Lingjie Liao; Yi Feng; Yiming Shao; Hui Xing; Guanghua Lan; Jianjun Li; Yuhua Ruan; Dan Li
Journal:  BMC Infect Dis       Date:  2022-05-04       Impact factor: 3.667

3.  Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study.

Authors:  Yun Lan; Linghua Li; Xiang He; Fengyu Hu; Xizi Deng; Weiping Cai; Junbin Li; Xuemei Ling; Qinghong Fan; Xiaoli Cai; Liya Li; Feng Li; Xiaoping Tang
Journal:  Virol J       Date:  2021-09-06       Impact factor: 4.099

4.  Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China.

Authors:  Chang Zhou; Shu Liang; Yiping Li; Yan Zhang; Ling Li; Li Ye; Dan Yuan; Ling Su
Journal:  BMC Infect Dis       Date:  2022-07-07       Impact factor: 3.667

5.  Molecular Network Analysis Reveals Transmission of HIV-1 Drug-Resistant Strains Among Newly Diagnosed HIV-1 Infections in a Moderately HIV Endemic City in China.

Authors:  Bin Zhao; Wei Song; Mingming Kang; Xue Dong; Xin Li; Lu Wang; Jianmin Liu; Haibo Ding; Zhenxing Chu; Lin Wang; Yu Qiu; Hong Shang; Xiaoxu Han
Journal:  Front Microbiol       Date:  2022-01-07       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.